Kembali
KLBF - Kalbe Farma

KLBF – Mitigates currency risk

16 April 2025

KLBF – Mitigates currency risk Kalbe Farma (KLBF) sets a more conservative growth target of 8–10% yoy for revenue and profit in 2025, slightly above its 2024 performance of 7.2% yoy revenue growth to IDR32.6 tn. In response to economic uncertainty and weakened consumer purchasing power, the company is focusing on the commercialization of new products and plans to increase its use of yuan in raw material purchases from China to mitigate currency volatility. Despite prevailing headwinds, management remains confident that its strategic adjustments will support the achievement of this year’s targets. (Source : Kontan)

Related Research

Consumer
KLBF - Terus bertumbuh di kuartal II/2022
Winny Rahardja 05 Agustus 2022 Lihat Detail
Healthcare
KLBF - 9M25 results came in-line on solid 3Q25 sales growth
Andre Suntono 31 Oktober 2025 Lihat Detail
Healthcare
KLBF - Sustaining growth further, after solid 1H25 results
Andre Suntono 28 Agustus 2025 Lihat Detail